Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Investors Relations - Information about investing in LCT - Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

Stock Exchange Announcements - 2008

05/06/2008 LCT Expands Diabetes Clinical Trial PDF
03/06/2008 LCT Lists on international OTCQX PDF
12/05/2008 LCT presents encapsulation technology at conference PDF
08/05/2008 LCT features on channel ten news PDF
08/05/2008 LCT prepares to list on international OTCQX PDF
30/04/2008 Appendix 4C - Qaurterly Report PDF(Appendix 4C) PDF
02/04/2008 LCT showcases proprietary nanotechnology PDF
31/03/2008 LCT announces compelling trial results PDF
19/03/2008 LCT recieves US$6m in share capital PDF
17/03/2008 LCT is issued 4th US patent PDF
27/02/2008 LCT and US based Barbara Davis Center collaborate on clinical trial PDF
13/02/2008 LCT to present positive preliminary clinical results PDF
13/02/2008 Change in Directors interest PDF
13/02/2008 Change in Directors interest PDF
12/02/2008 Diabetes trial supported by US-based diabetes Foundation PDF PDF
04/02/2008 Notice of General Meeting PDF
01/02/2008 Appendix 3B and Cleansing Statement PDF
31/01/2008 Appendix 4C- LCT in strong cash position PDF
25/01/2008 LCT announces conversion by noteholders PDF
09/01/2008 LCT to receive US$6m PDF
08/01/2008 LCT Announces new US Director PDF
13/12/2007 Becoming a substanital holder AXA PDF
05/12/2007 Appendix 3B PDF
30/11/2007 Appendix 3Y - Change in Directors Interest notice PDF
30/11/2007 LCT Receives A$6.0M in Capital Placement PDF
27/11/2007 Results of General Meeting Held on 27 November 2007 PDF
27/11/2007 LCT AGM Presentation PDF
27/11/2007 LCT Updates shareholders on Clinical Trial Progress at AGM PDF
22/11/2007 LCT to Cancel Rights At 20 cents PDF
21/11/2007 Form 604 PDF
08/11/2007 Becoming a substantial holder PDF
08/11/2007 Appendix 3B PDF
06/11/2007 LCT recieves initial Navigroup funding PDF
31/10/2007 Appendix 4C quarterly PDF
31/10/2007 Appendix 4C quarterly report PDF
30/10/2007 LCT announces further $6.4m capital placement PDF
23/10/2007 LCT presents at Rodman and Renshaw Healthcare conference PDF
22/10/2007 Further positive preliminary data on Diabecell trial PDF
09/10/2007 Positive preliminary phase I/IIa trial data PDF
28/09/2007 Full Year Statutory Accounts PDF
12/09/2007 Receives Ethics Approval for Diabetes Clinical Trial PDF
31/08/2007 Preliminary final report FYE 30/6/07 PDF
29/08/2007 LCT to feature on ABC TV 7.30 report PDF
24/08/2007 Appendix 3Z - Final Director's Interest Notice PDF
24/08/2007 Resignation of Director notice PDF
23/08/2007 Appendix 3X - Initial Director's Interest notice PDF
23/08/2007 LCT appoints Independent Director PDF
01/08/2007 Journal publishes durability of LCT biocapsule PDF
31/07/2007 Appendix 4C Quarterly report PDF
17/07/2007 LCT launches US ADR Level 1 listing PDF
05/07/2007 LCT receives Enterprise Development Grant PDF
02/07/2007 LCT appoints The Channel Group PDF
28/06/2007 Final Director’s Interest Notice PDF
28/06/2007 Resignation of Director PDF
26/06/2007 Change of Director’s Interest Notice PDF
25/06/2007 Change of Director’s Interest PDF
19/06/2007 Change of Director’s Interest Notice PDF
14/06/2007 DiabeCell clinical trial starts PDF
07/06/2007 Change of Director’s Interest Notice PDF
07/06/2007 Change of Director’s Interest Notice PDF
07/06/2007 Change of Director’s Interest Notice PDF
07/06/2007 Change of Director’s Interest Notice PDF
07/06/2007 Change of Director’s Interest Notice PDF
01/06/2007 General Meeting Resolutions PDF
22/05/2007 LCT awarded IANZ accreditation PDF
02/05/2007 Notice of General Meeting PDF
01/05/2007 LCT to present at US Venture Forum PDF
30/04/2007 Appendix 4C Quarterly Report PDF
17/04/2007 Regulatory review allows LCT clinical program
to proceed
PDF
12/04/2007 LCT to establish Level 1 American Depository
Receipt Program
PDF
30/03/2007 LCT reports major step forward for islet transplantation PDF
22/03/2007 Change of Director’s Interest Notice PDF
22/03/2007 Change of Director’s Interest Notice PDF
08/03/2007 Appendix 3B PDF
28/02/2007 LCT Half Yearly Report Ended 31 Dec 2006 PDF
27/02/2007 Change of Director's Interest Notice PDF
26/02/2007 Change of Director's Interest Notice PDF
26/02/2007 Change of Director's Interest Notice PDF
26/02/2007 Change of Director's Interest Notice PDF
26/02/2007 Initial Director's Interest Notice PDF
23/02/2007 Appointment of Executive Director PDF
22/02/2007 Appendix 3B PDF
14/02/2007 LCT Closes Successful Share Purchase Plan
and Placement
PDF
05/02/2007 February Newsletter PDF
02/02/2007 Underwriting of Share Purchase Plan PDF
31/01/2007 Commitments Test Entity - Second Quarter Report PDF
30/01/2007 To start clinical trial of Type 1 diabetes treatment PDF
24/01/2007 Appoints CEO as Company Heads into New Phase PDF
19/01/2007 Appendix 3B and Relief Under Corps Act Section 708A(5)(e) PDF
17/01/2007 Opens Share Purchase Plan Offer PDF

Archive 2006

Archive 2005


LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd